Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 184

1.

Structurally designed attenuated subunit vaccines for S. aureus LukS-PV and LukF-PV confer protection in a mouse bacteremia model.

Karauzum H, Adhikari RP, Sarwar J, Devi VS, Abaandou L, Haudenschild C, Mahmoudieh M, Boroun AR, Vu H, Nguyen T, Warfield KL, Shulenin S, Aman MJ.

PLoS One. 2013 Jun 7;8(6):e65384. doi: 10.1371/journal.pone.0065384. Print 2013.

2.

Bacterial two-component and hetero-heptameric pore-forming cytolytic toxins: structures, pore-forming mechanism, and organization of the genes.

Kaneko J, Kamio Y.

Biosci Biotechnol Biochem. 2004 May;68(5):981-1003. Review. Erratum in: Biosci Biotechnol Biochem. 2004 Jun;68(6):A4.

3.

Novel structurally designed vaccine for S. aureus α-hemolysin: protection against bacteremia and pneumonia.

Adhikari RP, Karauzum H, Sarwar J, Abaandou L, Mahmoudieh M, Boroun AR, Vu H, Nguyen T, Devi VS, Shulenin S, Warfield KL, Aman MJ.

PLoS One. 2012;7(6):e38567. doi: 10.1371/journal.pone.0038567. Epub 2012 Jun 6.

4.

Analysis of the specificity of Panton-Valentine leucocidin and gamma-hemolysin F component binding.

Meyer F, Girardot R, Piémont Y, Prévost G, Colin DA.

Infect Immun. 2009 Jan;77(1):266-73. doi: 10.1128/IAI.00402-08. Epub 2008 Oct 6.

5.

A serologic correlate of protective immunity against community-onset Staphylococcus aureus infection.

Fritz SA, Tiemann KM, Hogan PG, Epplin EK, Rodriguez M, Al-Zubeidi DN, Bubeck Wardenburg J, Hunstad DA.

Clin Infect Dis. 2013 Jun;56(11):1554-61. doi: 10.1093/cid/cit123. Epub 2013 Feb 27.

6.

α-Defensins partially protect human neutrophils against Panton-Valentine leukocidin produced by Staphylococcus aureus.

Cardot-Martin E, Casalegno JS, Badiou C, Dauwalder O, Keller D, Prévost G, Rieg S, Kern WV, Cuerq C, Etienne J, Vandenesch F, Lina G, Dumitrescu O.

Lett Appl Microbiol. 2015 Aug;61(2):158-64. doi: 10.1111/lam.12438. Epub 2015 Jun 1.

PMID:
25963798
7.

The interaction of Staphylococcus aureus bi-component gamma-hemolysins and leucocidins with cells and lipid membranes.

Ferreras M, Höper F, Dalla Serra M, Colin DA, Prévost G, Menestrina G.

Biochim Biophys Acta. 1998 Nov 11;1414(1-2):108-26.

PMID:
9804914
8.
9.

Five birds, one stone: neutralization of α-hemolysin and 4 bi-component leukocidins of Staphylococcus aureus with a single human monoclonal antibody.

Rouha H, Badarau A, Visram ZC, Battles MB, Prinz B, Magyarics Z, Nagy G, Mirkina I, Stulik L, Zerbs M, Jägerhofer M, Maierhofer B, Teubenbacher A, Dolezilkova I, Gross K, Banerjee S, Zauner G, Malafa S, Zmajkovic J, Maier S, Mabry R, Krauland E, Wittrup KD, Gerngross TU, Nagy E.

MAbs. 2015;7(1):243-54. doi: 10.4161/19420862.2014.985132.

PMID:
25523282
10.

Heavy chain-only antibodies and tetravalent bispecific antibody neutralizing Staphylococcus aureus leukotoxins.

Laventie BJ, Rademaker HJ, Saleh M, de Boer E, Janssens R, Bourcier T, Subilia A, Marcellin L, van Haperen R, Lebbink JH, Chen T, Prévost G, Grosveld F, Drabek D.

Proc Natl Acad Sci U S A. 2011 Sep 27;108(39):16404-9. doi: 10.1073/pnas.1102265108. Epub 2011 Sep 19.

11.

Development of a novel multiplex electrochemiluminescent-based immunoassay for quantification of human serum IgG against 10 Staphylococcus aureus toxins.

Adhikari RP, Haudenschild C, Sterba PM, Sahandi S, Enterlein S, Holtsberg FW, Aman MJ.

J Immunol Methods. 2016 Mar;430:33-42. doi: 10.1016/j.jim.2016.01.013. Epub 2016 Jan 27.

PMID:
26826278
12.

Panton-Valentine leucocidin and gamma-hemolysin from Staphylococcus aureus ATCC 49775 are encoded by distinct genetic loci and have different biological activities.

Prévost G, Cribier B, Couppié P, Petiau P, Supersac G, Finck-Barbançon V, Monteil H, Piemont Y.

Infect Immun. 1995 Oct;63(10):4121-9.

13.

Engineering of the LukS-PV and LukF-PV subunits of Staphylococcus aureus Panton-Valentine leukocidin for diagnostic and therapeutic applications.

Okolie CE, Cockayne A, Penfold C, James R.

BMC Biotechnol. 2013 Nov 19;13:103. doi: 10.1186/1472-6750-13-103.

14.

The signal peptide of Staphylococcus aureus panton valentine leukocidin LukS component mediates increased adhesion to heparan sulfates.

Tristan A, Benito Y, Montserret R, Boisset S, Dusserre E, Penin F, Ruggiero F, Etienne J, Lortat-Jacob H, Lina G, Bowden MG, Vandenesch F.

PLoS One. 2009;4(4):e5042. doi: 10.1371/journal.pone.0005042. Epub 2009 Apr 6.

15.

Identification and validation of a linear protective neutralizing epitope in the β-pore domain of alpha toxin.

Oscherwitz J, Cease KB.

PLoS One. 2015 Jan 30;10(1):e0116882. doi: 10.1371/journal.pone.0116882. eCollection 2015.

16.

Staphylococcus aureus Panton-Valentine leukocidin induces an inflammatory response in human phagocytes via the NLRP3 inflammasome.

Holzinger D, Gieldon L, Mysore V, Nippe N, Taxman DJ, Duncan JA, Broglie PM, Marketon K, Austermann J, Vogl T, Foell D, Niemann S, Peters G, Roth J, Löffler B.

J Leukoc Biol. 2012 Nov;92(5):1069-81. doi: 10.1189/jlb.0112014. Epub 2012 Aug 14.

17.

Construction of a LukS-PV mutant of a staphylococcal Panton-Valentine leukocidin component having a high LukS-like function.

Shimatani A, Kaneko J, Tomita T, Kamio Y.

Biosci Biotechnol Biochem. 1999 Oct;63(10):1828-30.

18.

Differential Interaction of the Staphylococcal Toxins Panton-Valentine Leukocidin and γ-Hemolysin CB with Human C5a Receptors.

Spaan AN, Schiepers A, de Haas CJ, van Hooijdonk DD, Badiou C, Contamin H, Vandenesch F, Lina G, Gerard NP, Gerard C, van Kessel KP, Henry T, van Strijp JA.

J Immunol. 2015 Aug 1;195(3):1034-43. doi: 10.4049/jimmunol.1500604. Epub 2015 Jun 19.

PMID:
26091719
19.

Phage conversion of Panton-Valentine leukocidin in Staphylococcus aureus: molecular analysis of a PVL-converting phage, phiSLT.

Narita S, Kaneko J, Chiba J, Piémont Y, Jarraud S, Etienne J, Kamio Y.

Gene. 2001 May 2;268(1-2):195-206.

PMID:
11368915
20.

The Panton-Valentine leukocidin vaccine protects mice against lung and skin infections caused by Staphylococcus aureus USA300.

Brown EL, Dumitrescu O, Thomas D, Badiou C, Koers EM, Choudhury P, Vazquez V, Etienne J, Lina G, Vandenesch F, Bowden MG.

Clin Microbiol Infect. 2009 Feb;15(2):156-64. doi: 10.1111/j.1469-0691.2008.02648.x. Epub 2008 Dec 22.

Items per page

Supplemental Content

Write to the Help Desk